CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Spyre Therapeutics Grants 11,138 Stock Options, 3,195 RSUs to Two Employees

By Public Technologies
  • Spyre Therapeutics approved options covering 11,138 shares for two non-executive employees on November 2, 2026, under its 2018 Equity Inducement Plan.
  • The awards also include 3,195 restricted stock units.
  • Stock options carry a 10-year term with a $95.51 exercise price.
  • Options vest 25% on each employee's first start-date anniversary, then 1/48 monthly, subject to continuous service.
  • RSUs vest 25% annually on anniversaries of the next November 15 on or after each employee's start date, subject to continuous service.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spyre Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611061605PRIMZONEFULLFEED9869315) on November 06, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk